Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Sofosbuvir and Daclatasvir for the Treatment of Covid-19 Outpatients: A Double-Blind, Randomized Controlled Trial
Abbass Soleimani
Abbass Soleimani

Associate Professor of Cardiology

Department Cardiology

School of Medicine

Sina Hospital

Tehran University of Medical Sciences

All Documents
1. Relationship Between St-Segment Resolution and Clinical Outcomes After Primary Percutaneous Coronary Intervention of Bifurcation Lesion in Patients With St Elevation Myocardial Infarction: A Cohort Study, Health Science Reports (2026)
2. A Comparative Analysis of Echocardiographic Data for Heart Transplant Eligibility in Brain Death Cases, Egyptian Heart Journal (2025)
3. Prevalence of Coronary Artery Calcification in Non-Contrast Non Ecg-Gated Chest Ct Scan of Patients With Significant Stenosis in Conventional Angiography in Comparison to Patients Without Significant Stenosis: A Cross-Sectional Study, Health Science Reports (2025)
4. Risk Assessment for Mortality in Patients With St-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Retrospective Cohort Study, Health Science Reports (2024)
5. Clinical and Angiographic Predictors of Suboptimal Coronary Flow After Primary Percutaneous Coronary Intervention in Patients With St-Elevation Myocardial Infarction, ARYA Atherosclerosis (2023)
6. Novel Treatment for Glance Necrosis Due to Priapism; Presentation and Review of Literature, Urologia Journal (2023)
7. Acute Electrocardiogram Pseudoinfarction Pattern and Re-Versible Left Ventricular Systolic Dysfunction in a Patient With Diabetic Ketoacidosis and Hyperkalemia: A Case Report, Frontiers in Emergency Medicine (2022)
8. Effects of Angiotensin Receptor Blockers (Arbs) on Clinical Outcomes of Patients With Hypertension and Covid-19: A 7-Month Follow-Up Cohort Study, Journal of Cardiovascular and Thoracic Research (2022)
9. The Outcomes of Marginal Donor Hearts Compared With Ideal Donors: A Single-Center Experience in Iran, Korean Journal of Transplantation (2022)
10. The Pragmatic Role of Covid-19 on the Thrombus Grade of Patients With Contemporary St-Segment-Elevation Myocardial Infarction, Journal of Tehran University Heart Center (2022)
11. The Pragmatic Role of Covid-19 on the Thrombus Grade of Patients With Contemporary St-Segment-Elevation Myocardial Infarction, Journal of Tehran University Heart Center (2022)
12. 24/7 Primary Percutaneous Coronary Intervention As a National Program, Critical Pathways in Cardiology (2021)
13. A Look at the Article the Relationship Between Philosophy and Medicine in the Works of Imam Fakhr Razi; a Distinctive Model From Galen and Ibn Sina, Iranian Journal of Medical Ethics and History of Medicine (2021)
14. Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive Covid-19 Patients: A Randomized Triple-Blind Clinical Trial, American Journal of Hypertension (2021)
15. Management of St-Segment-Elevation Myocardial Infarction During the Coronavirus Disease 2019 (Covid-19) Outbreak: Iranian“247” National Committee's Position Paper on Primary Percutaneous Coronary Intervention, Catheterization and Cardiovascular Interventions (2021)
16. Management of St-Segment-Elevation Myocardial Infarction During the Coronavirus Disease 2019 (Covid-19) Outbreak: Iranian“247” National Committee's Position Paper on Primary Percutaneous Coronary Intervention, Catheterization and Cardiovascular Interventions (2021)
17. The Primary Angioplasty Registry of Sina (Pars); a Brief Report of Design and Rationale, Frontiers in Emergency Medicine (2021)
18. Effects of Angiotensin Receptor Blockers (Arbs) on In-Hospital Outcomes of Patients With Hypertension and Confirmed or Clinically Suspected Covid-19, American Journal of Hypertension (2020)
19. The Association Between Cardiac Injury and Outcomes in Hospitalized Patients With Covid-19, Internal and Emergency Medicine (2020)
20. Myocardial Infarction in a Patient With Multiple Sclerosis After Receiving Natalizumab, Multiple Sclerosis and Related Disorders (2018)